These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 36926335)

  • 21. BST1 rs4698412 allelic variant increases the risk of gait or balance deficits in patients with Parkinson's disease.
    Shen YT; Wang JW; Wang M; Zhi Y; Li JY; Yuan YS; Wang XX; Zhang H; Zhang KZ
    CNS Neurosci Ther; 2019 Apr; 25(4):422-429. PubMed ID: 30676692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.
    Cui G; Li S; Ye H; Yang Y; Huang Q; Chu Y; Shi Z; Zhang X
    Front Immunol; 2022; 13():956005. PubMed ID: 36159838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphism of neurodegeneration-related genes associated with Parkinson's disease risk.
    Li J; Yi M; Li B; Yin S; Zhang Y; Huang Z; Shu L; Zhang Y
    Neurol Sci; 2022 Sep; 43(9):5301-5312. PubMed ID: 35695987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCDC62 variant rs12817488 is associated with the risk of Parkinson's disease in a Han Chinese population.
    Liu RR; Zhou LL; Cheng X; Sun MX; Hu YB; Chen SF; Zhang X; Zhu JH
    Eur Neurol; 2014; 71(1-2):77-83. PubMed ID: 24335092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible association of CCDC62 rs12817488 polymorphism and Parkinson's disease risk in Chinese population: a meta-analysis.
    Lu Y; Tan L; Shen N; Peng J; Wang C; Zhu Y; Wang X
    Sci Rep; 2016 Apr; 6():23991. PubMed ID: 27035708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of slow acetylator genotype of N-acetyltransferase 2 with Parkinson's disease in south Indian population.
    Pandi S; Chinniah R; Sevak V; Ravi PM; Vijayan M; Vellaiappan NA; Karuppiah B
    Neurosci Lett; 2020 Sep; 735():135260. PubMed ID: 32682841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polygenic determinants of Parkinson's disease in a Chinese population.
    Guo JF; Li K; Yu RL; Sun QY; Wang L; Yao LY; Hu YC; Lv ZY; Luo LZ; Shen L; Jiang H; Yan XX; Pan Q; Xia K; Tang BS
    Neurobiol Aging; 2015 Apr; 36(4):1765.e1-1765.e6. PubMed ID: 25623333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease.
    Bandmann O; Vaughan J; Holmans P; Marsden CD; Wood NW
    Lancet; 1997 Oct; 350(9085):1136-9. PubMed ID: 9343502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population.
    Clarimon J; Eerola J; Hellström O; Tienari PJ; Singleton A
    Neurosci Lett; 2004 Sep; 367(2):168-70. PubMed ID: 15331145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated Schwann cells and increased inflammatory cytokines IL-1β, IL-6, and TNF-α in patients' sural nerve are lack of tight relationship with specific sensory disturbances in Parkinson's disease.
    Zhang H; Wu J; Shen FF; Yuan YS; Li X; Ji P; Zhu L; Sun L; Ding J; Niu Q; Zhang KZ
    CNS Neurosci Ther; 2020 May; 26(5):518-526. PubMed ID: 31828965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR.
    McKeown-Eyssen G; Baines C; Cole DE; Riley N; Tyndale RF; Marshall L; Jazmaji V
    Int J Epidemiol; 2004 Oct; 33(5):971-8. PubMed ID: 15256524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of gene polymorphism of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), cytochrome P450 2D6 (CYP2D6) and N-acetyltransferase 2 (NAT2) in pathogenesis of Parkinson's disease].
    Białecka M; Droździk M; Podraza H
    Neurol Neurochir Pol; 2002; 36(1):113-21. PubMed ID: 12053603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter polymorphisms in IL-6 gene influence pro-inflammatory cytokines for the risk of osteoarthritis.
    Singh M; Mastana S; Singh S; Juneja PK; Kaur T; Singh P
    Cytokine; 2020 Mar; 127():154985. PubMed ID: 31951965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease.
    Wahner AD; Sinsheimer JS; Bronstein JM; Ritz B
    Arch Neurol; 2007 Jun; 64(6):836-40. PubMed ID: 17562931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetically Predicted Levels of Circulating Inflammatory Cytokines and the Risk and Age at Onset of Parkinson's Disease: A Two-Sample Mendelian Randomization Study.
    Zhao Y; Zhang X; Guo N; Tian D; Zhang C; Mu C; Han C; Zhu R; Zhang J; Liu X
    Front Aging Neurosci; 2022; 14():811059. PubMed ID: 35299944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Paraoxonse1 (PON1) Genotypes with the Activity of PON1 in Patients with Parkinson's Disease.
    Mota A; Hemati-Dinarvand M; Akbar Taheraghdam A; Reza Nejabati H; Ahmadi R; Ghasemnejad T; Hasanpour M; Valilo M
    Acta Neurol Taiwan; 2019 Sep; 28(3)():66-74. PubMed ID: 32002976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptomic analysis reveals associations of blood-based A-to-I editing with Parkinson's disease.
    Li W; Wu H; Li J; Wang Z; Cai M; Liu X; Liu G
    J Neurol; 2024 Feb; 271(2):976-985. PubMed ID: 37902879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between CD157/BST1 polymorphisms and the susceptibility of Parkinson's disease: a meta-analysis.
    Li J; Luo J; Liu L; Fu H; Tang L
    Neuropsychiatr Dis Treat; 2019; 15():1089-1102. PubMed ID: 31118642
    [No Abstract]   [Full Text] [Related]  

  • 39. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.
    Liu X; Cheng R; Verbitsky M; Kisselev S; Browne A; Mejia-Sanatana H; Louis ED; Cote LJ; Andrews H; Waters C; Ford B; Frucht S; Fahn S; Marder K; Clark LN; Lee JH
    BMC Med Genet; 2011 Aug; 12():104. PubMed ID: 21812969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus.
    Tan EK; Kwok HH; Tan LC; Zhao WT; Prakash KM; Au WL; Pavanni R; Ng YY; Satake W; Zhao Y; Toda T; Liu JJ
    Neurology; 2010 Aug; 75(6):508-12. PubMed ID: 20697102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.